Amgen's late-stage study of human monoclonal antibody Repatha hit its dual primary targets, demonstrating it significantly reduced the risk of major adverse cardiovascular events in individuals ...

Q. My doctor prescribed a Cologuard test instead of a colonoscopy. No one mentioned how often Cologuard could result in false positive test results, as mine did. So, a colonoscopy was necessary after ...

Amgen (AMGN) stock is in focus as its cholesterol drug Repatha succeeds in a Phase 3 trial, reducing the risk of major adverse cardiovascular events. Read more here.

In a first-of-its-kind finding, Amgen’s PCSK9 drug protected heart health when tested as a “primary prevention” therapy, which could pave the way for access to a much broader population.

Melissa Quinn is a politics reporter for CBSNews.com, where she covers U.S. politics, with a focus on the Supreme Court and federal courts. Washington — A federal judge ruled Wednesday that the Trump ...

Washington — A federal judge in California ruled Friday that the Trump administration's attempt to end the Temporary Protected Status program for hundreds of thousands of Venezuelan and Haitian ...

The court has been largely receptive to the administration’s claims of executive power. By Adam Liptak Reporting from Washington The Trump administration returned to the Supreme Court for a third time ...

Settlement talks between the Trump administration and Harvard University have stalled, according to a report from The New York Times published Saturday. "The White House has not issued any new demands ...

A federal court rejected an appeal by the Trump administration Thursday to deny transgender and nonbinary Americans passports reflecting their gender identity, upholding a preliminary injunction ...